Saturday, January 14, 2017

Fat Mass Reduction With Adipocyte Hypertrophy and Insulin Resistance in Heterozygous PPARgamma Mutant Rats

http://type2diabetestreatment.net/obesity-help/fat-mass-reduction-with-adipocyte-hypertrophy-and-insulin-resistance-in-heterozygous-ppargamma-mutant-rats/
Skip to main content Fat Mass Reduction With Adipocyte Hypertrophy and Insulin Resistance in Heterozygous PPARγ Mutant Rats PreviousNext

  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Abstract

Agonist-induced activation of peroxisome proliferator–activated receptor-γ (PPARγ) stimulates adipocyte differentiation and insulin sensitivity. Patients with heterozygous PPARγ dominant-negative mutation develop partial lipodystrophy and insulin resistance. Inconsistent with this evidence in humans, it was reported that heterozygous PPARγ knockout mice have increased insulin sensitivity and that mice with heterozygous PPARγ dominant-negative mutation have normal insulin sensitivity and improved glucose tolerance. In the context of the interspecies intranslatability of PPARγ-related findings, we generated a PPARγ mutant rat with a loss-of-function mutation (Ppargmkyo) without dominant-negative activity by using the ENU (N-ethyl-N-nitrosourea) mutagenesis method. Heterozygous Ppargmkyo/+ rats showed reduced fat mass with adipocyte hypertrophy and insulin resistance, which were highly predictable from known actions of PPARγ agonists and phenotypes of patients with the PPARγ mutation. This report is the first in our knowledge to clearly demonstrate that both alleles of PPARγ are required for normal adipocyte development and insulin sensitivity in vivo. Furthermore, the study indicates that PPARγ regulates mainly adipocyte number rather than adipocyte size in vivo. The choice of appropriate species as experimental models is critical, especially for the study of PPARγ.

Footnotes

  • This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db15-1422/-/DC1.

  • Received October 13, 2015.
  • Accepted June 30, 2016.
  • © 2016 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

View Full Text

Log in using your username and password

PreviousNext Back to top Diabetes: 66 (1)

Current Issue

January 2017, 66(1) Article Alerts Email Article Citation Tools Fat Mass Reduction With Adipocyte Hypertrophy and Insulin Resistance in Heterozygous PPARγ Mutant Rats Valentino Gumbilai, Ken Ebihara, Megumi Aizawa-Abe, Chihiro Ebihara, Mingming Zhao, Yuji Yamamoto, Tomoji Mashimo, Kiminori Hosoda, Tadao Serikawa, Kazuwa Nakao

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

  • Reduction of Hypothalamic Endoplasmic Reticulum Stress Activates Browning of White Fat and Ameliorates Obesity
  • Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial
  • Increased Interleukin-32 Levels in Obesity Promote Adipose Tissue Inflammation and Extracellular Matrix Remodeling: Effect of Weight Loss

Similar Articles

Type 2 Diabetes Treatment
Type 2 Diabetes Diet
Diabetes Destroyer Reviews
Original Article
#ObesityHelp

No comments:

Post a Comment